Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Thousands of men with advanced prostate cancer are to miss out on a life-extending drug because of new NHS restrictions.
Enzalutamide prolongs life by at least five months in men who have run out of treatment options – with some surviving more than 18 months.
But health chiefs in England are issuing guidance which will stop it being prescribed to patients who have already received a different new drug called abiraterone.
http://www.dailymail.co.uk/health/a...ine-not-given-men-received-new-treatment.html
Enzalutamide prolongs life by at least five months in men who have run out of treatment options – with some surviving more than 18 months.
But health chiefs in England are issuing guidance which will stop it being prescribed to patients who have already received a different new drug called abiraterone.
http://www.dailymail.co.uk/health/a...ine-not-given-men-received-new-treatment.html